SS-31 (Elamipretide) — mitochondrial protection in models

SS-31 is a synthetic tetrapeptide from the Szeto–Schiller peptide family (hence the designation "SS"), also known by the development name elamipretide (previously described as MTP-131 / Bendavia). Its sequence — D-Arg-2',6'-dimethyltyrosine-Lys-Phe-amide — belongs to the class of aromatic-cationic peptides: they combine positively charged amino acid residues with aromatic fragments, which in research allows them to penetrate the interior of the mitochondrion without the involvement of transporters. It is precisely the mitochondrion — or more specifically its inner membrane — that makes SS-31 a subject of intensive research on cellular bioenergetics.

Unlike many research peptides, SS-31 does not act through a membrane receptor. Its "target" is a specific structural lipid of the inner mitochondrial membrane. This unusual mechanism — along with one of the better preclinically documented track records in the area of mitochondria — means the compound is frequently used as a tool for studying mitochondrial function.

Mechanism in brief

SS-31 binds selectively to cardiolipin — a phospholipid found almost exclusively in the inner mitochondrial membrane. The principle here resembles a lock-and-key model: the peptide molecule recognizes cardiolipin and embeds itself in the membrane, instead of dispersing throughout the entire cell. One can think of it as a precise screwdriver aimed at a single element, rather than a hammer acting everywhere at once.

Cardiolipin organizes the folds of the inner membrane (cristae) and keeps the respiratory chain complexes (electron transport chain) in check. In models where cardiolipin is oxidized or disorganized, a "leak" of electrons and increased production of reactive oxygen species (ROS) is observed. Research attributes to SS-31 the role of a stabilizer of this structure — with consequences for the efficiency of electron transport and ATP synthesis, which are assessed in experimental systems, not in humans.

What is being studied

The following areas describe what and in which model is being studied. Each of them refers to mitochondrial processes, not to effects in humans.

• Mitochondrial integrity and cristae structure — in isolated mitochondria and cell lines, the compound's effect on the organization of the inner membrane and the stability of respiratory chain complexes under stress conditions is studied.
• Oxidative stress and bioenergetics — in cellular and animal models, the relationship between cardiolipin binding and ROS production, as well as indicators of ATP synthesis efficiency (mitochondrial respiration), is analyzed.
• Cardiac ischemia-reperfusion injury — SS-31 is studied in animal models of myocardial ischemia and reperfusion in the context of preserving mitochondrial function after a hypoxic episode.
• Mitochondrial myopathy and aging skeletal muscle — in animal models it is evaluated in the context of muscle mitochondrial function and the bioenergetic capacity of the tissue.

In all cases, these are observations from experimental models, accompanied by the caveat that they require further research.

Origin and historical context

The Szeto–Schiller peptides were described in the early 2000s by the teams of Hazel Szeto and Peter Schiller (among others, at Weill Cornell Medical College). The aromatic-cationic class was created as a tool for the targeted delivery of molecules to mitochondria. SS-31 became the best-studied representative of this family.

Under the name elamipretide, the compound was developed in clinical programs by Stealth BioTherapeutics, among others in the context of primary mitochondrial myopathy, Barth syndrome, and geographic atrophy in the dry form of AMD (age-related macular degeneration). It is worth stating honestly: some of the primary endpoints in clinical trials were not met, and the interpretation of the results remains a subject of scientific debate.

Research specification

SS-31 is usually supplied as a lyophilisate (lyophilised powder) for laboratory applications. The quality standard in research is purity determination by HPLC and confirmation of the compound's identity — these parameters are described in analytical documents (COA) and safety data sheets, available in the safety data sheets section. High HPLC purity refers to the quality of the material for research work and does not constitute a promise of any biological activity.

Level of evidence

An honest summary of the state of knowledge:

• In vitro / isolated mitochondria: a solid body of data describing cardiolipin binding and the effect on bioenergetic parameters under controlled conditions.
• Animal models: SS-31 is among the better preclinically documented mitochondrial compounds; the data cover various organs and models of metabolic stress.
• Human data: limited and inconclusive — the compound advanced to the clinical evaluation phase, but the results are mixed and do not allow for drawing conclusions about its activity.

The whole requires further research, and extrapolating observations from models to humans is unwarranted.

For research purposes only. Not for consumption by humans or animals.